Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Study reveals mechanisms by which SGLT2 inhibitors produce renoprotective effect

SGLT2 inhibitors (gliflozins) were developed as oral antidiabetics. They enhance urinary glucose excretion by inhibiting SGLT-2 (sodium-dependent glucose co-transporter-2) in the renal tubuli.

8 Jun 2021

Cows can pass on hypoglycin A toxin through their milk, shows study

Cows can pass on the hypoglycin A toxin through their milk, a study by the Martin Luther University Halle-Wittenberg (MLU) and the Leibniz Institute of Plant Biochemistry (IPB) in Toxins shows. The substance can cause severe symptoms in humans and animals.

8 Jun 2021

Researchers develop promising stem cell therapy to treat type 1 diabetes

Type 1 diabetes, which arises when the pancreas doesn't create enough insulin to control levels of glucose in the blood, is a disease that currently has no cure and is difficult for most patients to manage.

8 Jun 2021

Healthy habits of pregnancy – latest science show maternal habits affect pregnancy success

Four new studies investigating the effects of supplements, eating habits and physical activity and how they can affect various aspects of health during pregnancy are being presented at NUTRITION 2021 LIVE ONLINE.

7 Jun 2021

Increasing a protein concentrated in brown fat may lower diabetes risk

Increasing a protein concentrated in brown fat appears to lower blood sugar, promote insulin sensitivity, and protect against fatty liver disease by remodeling white fat to a healthier state, a new study led by UT Southwestern scientists suggests.

5 Jun 2021

Weight loss drug Wegovy approved by FDA

The U.S. Food and Drug Administration (FDA) has approved Wegovy (semaglutide) injection (2.4 mg once weekly) as a chronic weight management treatment in obese or overweight adults with a weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), when used along with calorie restriction and physical activity. Wegovy, is a more potent version of Novo Nordisk's diabetes drug semaglutide.

4 Jun 2021

Eating at least two servings of fruit per day reduces diabetes risk by 36%

Researchers at Edith Cowan University revealed that people who consumed at least two servings of fruit per day had higher measures of insulin sensitivity than those who ate less than a half serving. The study, published in the Journal of Clinical Endocrinology and Metabolism, showed that a healthy diet including whole fruits, but not fruit juice, may play a role in mitigating type 2 diabetes risk.

4 Jun 2021

New scientific evidence supports the health benefits of superfoods

Researchers will be presenting their findings at the NUTRITION 2021 LIVE ONLINE conference on the science behind the health benefits of certain superfoods.

4 Jun 2021

Tiny implant reverses diabetes in mice without requiring drugs

A team of researchers led by diabetes specialists and biomedical engineers at Washington University School of Medicine in St. Louis and Cornell University has demonstrated that, using a miniscule device, they can implant insulin-secreting cells into diabetic mice.

3 Jun 2021

Gut-brain communication by distinct nerve cells differently controls satiety and blood sugar levels

The gut and the brain communicate with each other in order to adapt satiety and blood sugar levels during food consumption.

2 Jun 2021

NIH-supported study aims to improve gestational diabetes screening and diagnosis

A new study supported by the National Institutes of Health aims to improve gestational diabetes screening and diagnosis by better understanding blood glucose levels throughout pregnancy.

2 Jun 2021

Doctors tell how to make the most of your telehealth visits

When the pandemic sidelined in-office visits at his practice, Dr. Dael Waxman "wasn't exactly thrilled with being at home." But he quickly shifted gears to video and telephone appointments.

2 Jun 2021

Glycosylated hemoglobin can provide a useful estimate of atherosclerosis and cardiovascular events

The routine use of the glycosylated hemoglobin test to track blood sugar levels in the general population can identify individuals with more advanced atherosclerotic disease.

1 Jun 2021

Diabetes remission diet can provide blood pressure control, reduce the need for anti-hypertensive drugs

New research has shown that if people achieve and maintain substantial weight loss to manage their type 2 diabetes, many can also effectively control their high blood pressure and stop or cut down on their anti-hypertensive medication.

31 May 2021

Study explains why the same exercise have different effects in different people

Although everyone can benefit from exercise, the mechanistic links between physical fitness and overall health are not fully understood, nor are the reasons why the same exercise can have different effects in different people.

27 May 2021

New immunotherapy shows promising results in subgroup of people with type 1 diabetes

A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body's own production of insulin.

24 May 2021

New global study highlights vast under-treatment of diabetes

Nearly half a billion people on the planet have diabetes, but most of them aren't getting the kind of care that could make their lives healthier, longer and more productive, according to a new global study of data from people with the condition.

22 May 2021

Asthma patients can benefit from type 2 diabetes medication

Type 2 diabetes patients who also have asthma are benefitting from a diabetes medication, typically given to help the pancreas produce more insulin, that also improves asthma symptoms and may reduce lung and airway inflammation.

21 May 2021

Blocking ABCB10 protein in liver cells protects against high blood sugar, fatty liver disease

A new multi-institution study led by a team of researchers at the David Geffen School of Medicine demonstrated that blocking a protein called ABCB10 in liver cells protects against high blood sugar and fatty liver disease in obese mice.

20 May 2021

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo

18 May 2021

Blood Sugar News and Research

Further Reading

Study reveals mechanisms by which SGLT2 inhibitors produce renoprotective effect

Cows can pass on hypoglycin A toxin through their milk, shows study

Researchers develop promising stem cell therapy to treat type 1 diabetes

Healthy habits of pregnancy – latest science show maternal habits affect pregnancy success

Increasing a protein concentrated in brown fat may lower diabetes risk

Weight loss drug Wegovy approved by FDA

Eating at least two servings of fruit per day reduces diabetes risk by 36%

New scientific evidence supports the health benefits of superfoods

Tiny implant reverses diabetes in mice without requiring drugs

Gut-brain communication by distinct nerve cells differently controls satiety and blood sugar levels

NIH-supported study aims to improve gestational diabetes screening and diagnosis

Doctors tell how to make the most of your telehealth visits

Glycosylated hemoglobin can provide a useful estimate of atherosclerosis and cardiovascular events

Diabetes remission diet can provide blood pressure control, reduce the need for anti-hypertensive drugs

Study explains why the same exercise have different effects in different people

New immunotherapy shows promising results in subgroup of people with type 1 diabetes

New global study highlights vast under-treatment of diabetes

Asthma patients can benefit from type 2 diabetes medication

Blocking ABCB10 protein in liver cells protects against high blood sugar, fatty liver disease

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News